Zoetis (ZTS) |
United States |
$79.725B |
30.68 |
Takeda Pharmaceutical (TAK) |
Japan |
$42.828B |
8.91 |
Astellas Pharma (ALPMY) |
Japan |
$18.694B |
17.22 |
Sandoz Group AG (SDZNY) |
Switzerland |
$18.434B |
0.00 |
United Therapeutics (UTHR) |
United States |
$16.172B |
15.91 |
Summit Therapeutics (SMMT) |
United States |
$13.252B |
0.00 |
Neurocrine Biosciences (NBIX) |
United States |
$13.057B |
34.57 |
Shionogi (SGIOY) |
Japan |
$12.165B |
12.19 |
Catalent (CTLT) |
United States |
$11.297B |
0.00 |
Madrigal Pharmaceuticals (MDGL) |
United States |
$6.822B |
0.00 |
Orion OYJ (ORINY) |
Finland |
$6.605B |
18.57 |
Corcept Therapeutics (CORT) |
United States |
$6.162B |
46.67 |
Ionis Pharmaceuticals (IONS) |
United States |
$6.041B |
0.00 |
Crinetics Pharmaceuticals (CRNX) |
United States |
$5.302B |
0.00 |
PTC Therapeutics (PTCT) |
United States |
$3.855B |
0.00 |
Dyne Therapeutics (DYN) |
United States |
$2.883B |
0.00 |
Catalyst Pharmaceuticals (CPRX) |
United States |
$2.637B |
11.95 |
AMNEAL PHARMACEUTICALS, INC (AMRX) |
United States |
$2.525B |
15.09 |
NewAmsterdam Pharma (NAMS) |
Netherlands |
$2.420B |
0.00 |
Centessa Pharmaceuticals (CNTA) |
United Kingdom |
$2.247B |
0.00 |
Recursion Pharmaceuticals (RXRX) |
United States |
$2.138B |
0.00 |
Soleno Therapeutics (SLNO) |
United States |
$2.042B |
0.00 |
Xencor (XNCR) |
United States |
$1.770B |
0.00 |
Evotec AG (EVO) |
Germany |
$1.655B |
0.00 |
BioCryst Pharmaceuticals (BCRX) |
United States |
$1.643B |
0.00 |
Indivior (INDV) |
United States |
$1.615B |
6.58 |
Guardian Pharmacy Services (GRDN) |
United States |
$1.539B |
0.00 |
Aurinia Pharmaceuticals Inc (AUPH) |
Canada |
$1.495B |
0.00 |
Ocular Therapeutix (OCUL) |
United States |
$1.484B |
0.00 |
Harrow (HROW) |
United States |
$1.345B |
0.00 |
ARS Pharmaceuticals (SPRY) |
United States |
$1.259B |
0.00 |
Ardelyx (ARDX) |
United States |
$1.248B |
0.00 |
Enliven Therapeutics (ELVN) |
United States |
$1.162B |
0.00 |
Collegium Pharmaceutical (COLL) |
United States |
$0.972B |
5.31 |
Avadel Pharmaceuticals (AVDL) |
Ireland |
$0.964B |
0.00 |
Bioventus (BVS) |
United States |
$0.927B |
29.28 |
Oruka Therapeutics (ORKA) |
United States |
$0.835B |
0.00 |
Cronos Group (CRON) |
Canada |
$0.768B |
0.00 |
Relay Therapeutics (RLAY) |
United States |
$0.742B |
0.00 |
USANA Health Sciences (USNA) |
United States |
$0.734B |
13.60 |
Tourmaline Bio (TRML) |
United States |
$0.641B |
0.00 |
Altimmune (ALT) |
United States |
$0.641B |
0.00 |
Elite Pharmaceuticals (ELTP) |
United States |
$0.611B |
0.00 |
Esperion Therapeutics (ESPR) |
United States |
$0.599B |
0.00 |
Ironwood Pharmaceuticals (IRWD) |
United States |
$0.595B |
0.00 |
ProKidney (PROK) |
United States |
$0.595B |
0.00 |
Savara (SVRA) |
United States |
$0.577B |
0.00 |
OmniAb (OABI) |
United States |
$0.573B |
0.00 |
Verve Therapeutics (VERV) |
United States |
$0.569B |
0.00 |
Xeris Biopharma Holdings (XERS) |
United States |
$0.534B |
0.00 |
Theravance Biopharma (TBPH) |
Cayman Islands |
$0.496B |
0.00 |
Organogenesis (ORGO) |
United States |
$0.488B |
0.00 |
Zevra Therapeutics (ZVRA) |
United States |
$0.475B |
0.00 |
KalVista Pharmaceuticals (KALV) |
United States |
$0.467B |
0.00 |
Siga Technologies (SIGA) |
United States |
$0.462B |
5.39 |
Korro Bio (KRRO) |
United States |
$0.438B |
0.00 |
Akebia Therapeutics (AKBA) |
United States |
$0.432B |
0.00 |
Larimar Therapeutics (LRMR) |
United States |
$0.419B |
0.00 |
Rigel Pharmaceuticals (RIGL) |
United States |
$0.362B |
146.86 |
Aquestive Therapeutics (AQST) |
United States |
$0.348B |
0.00 |
Avita Medical (RCEL) |
United States |
$0.346B |
0.00 |
4D Molecular Therapeutics (FDMT) |
United States |
$0.335B |
0.00 |
Aldeyra Therapeutics (ALDX) |
United States |
$0.315B |
0.00 |
Amylyx Pharmaceuticals (AMLX) |
United States |
$0.309B |
0.00 |
Nature's Sunshine Products (NATR) |
United States |
$0.301B |
17.89 |
Lexeo Therapeutics (LXEO) |
United States |
$0.276B |
0.00 |
Heron Therapeutics (HRTX) |
United States |
$0.268B |
0.00 |
Lyell Immunopharma (LYEL) |
United States |
$0.267B |
0.00 |
Aclaris Therapeutics (ACRS) |
United States |
$0.259B |
0.00 |
Silence Therapeutics (SLN) |
United Kingdom |
$0.221B |
0.00 |
Inhibikase Therapeutics (IKT) |
United States |
$0.215B |
0.00 |
Acrivon Therapeutics (ACRV) |
United States |
$0.214B |
0.00 |
Corbus Pharmaceuticals Holdings (CRBP) |
United States |
$0.195B |
0.00 |
Profound Medical (PROF) |
Canada |
$0.190B |
0.00 |
Nektar Therapeutics (NKTR) |
United States |
$0.188B |
0.00 |
MediWound (MDWD) |
Israel |
$0.185B |
0.00 |
Enanta Pharmaceuticals (ENTA) |
United States |
$0.183B |
0.00 |
Telomir Pharmaceuticals (TELO) |
United States |
$0.165B |
0.00 |
CytoDyn (CYDY) |
United States |
$0.164B |
0.00 |
Metagenomi (MGX) |
United States |
$0.157B |
0.00 |
Nanobiotix S.A (NBTX) |
France |
$0.155B |
0.00 |
Achieve Life Sciences (ACHV) |
Canada |
$0.151B |
0.00 |
VAXART, INC (VXRT) |
United States |
$0.142B |
0.00 |
Cassava Sciences (SAVA) |
United States |
$0.139B |
0.00 |
Protara Therapeutics (TARA) |
United States |
$0.129B |
0.00 |
Inotiv (NOTV) |
United States |
$0.126B |
0.00 |
Fractyl Health (GUTS) |
United States |
$0.121B |
0.00 |
Galectin Therapeutics (GALT) |
United States |
$0.121B |
0.00 |
Century Therapeutics (IPSC) |
United States |
$0.120B |
0.00 |
Cardiol Therapeutics (CRDL) |
Canada |
$0.118B |
0.00 |
Context Therapeutics (CNTX) |
United States |
$0.117B |
0.00 |
Journey Medical (DERM) |
United States |
$0.114B |
0.00 |
Innate Pharma SA (IPHYF) |
France |
$0.108B |
0.00 |
Regulus Therapeutics (RGLS) |
United States |
$0.107B |
0.00 |
Avalo Therapeutics (AVTX) |
United States |
$0.101B |
0.00 |
Pyxis Oncology (PYXS) |
United States |
$0.100B |
0.00 |
Karyopharm Therapeutics (KPTI) |
United States |
$0.092B |
0.00 |
Assertio Holdings (ASRT) |
United States |
$0.091B |
23.90 |
Arch Biopartners (ACHFF) |
Canada |
$0.088B |
0.00 |
ElectroCore (ECOR) |
United States |
$0.087B |
0.00 |
Reviva Pharmaceuticals Holdings (RVPH) |
United States |
$0.084B |
0.00 |
Unicycive Therapeutics (UNCY) |
United States |
$0.083B |
0.00 |
PMV Pharmaceuticals (PMVP) |
United States |
$0.083B |
0.00 |
Swiftmerge Acquisition (IVCP) |
United States |
$0.077B |
0.00 |
OptiNose (OPTN) |
United States |
$0.076B |
0.00 |
Vivani Medical (VANI) |
United States |
$0.076B |
0.00 |
ESSA Pharma (EPIX) |
Canada |
$0.075B |
0.00 |
Champions Oncology (CSBR) |
United States |
$0.071B |
0.00 |
Scienture Holdings (SCNX) |
United States |
$0.068B |
0.00 |
Mural Oncology (MURA) |
Ireland |
$0.066B |
0.00 |
Iterum Therapeutics (ITRM) |
Ireland |
$0.063B |
0.00 |
AlloVir (ALVR) |
United States |
$0.059B |
0.00 |
Prelude Therapeutics (PRLD) |
United States |
$0.053B |
0.00 |
CASI Pharmaceuticals (CASI) |
China |
$0.053B |
0.00 |
Nutriband (NTRB) |
United States |
$0.052B |
0.00 |
BioVie (BIVI) |
United States |
$0.049B |
0.00 |
SCYNEXIS (SCYX) |
United States |
$0.047B |
0.00 |
Rafael Holdings (RFL) |
United States |
$0.046B |
0.00 |
Gain Therapeutics (GANX) |
United States |
$0.045B |
0.00 |
Verrica Pharmaceuticals (VRCA) |
United States |
$0.040B |
0.00 |
VYNE Therapeutics (VYNE) |
United States |
$0.039B |
0.00 |
Tempest Therapeutics (TPST) |
United States |
$0.039B |
0.00 |
FibroGen (FGEN) |
United States |
$0.037B |
0.00 |
Tonix Pharmaceuticals Holding (TNXP) |
United States |
$0.037B |
0.00 |
MARKER THERAPEUTICS, INC (MRKR) |
United States |
$0.036B |
0.00 |
Cumberland Pharmaceuticals (CPIX) |
United States |
$0.034B |
0.00 |
Surrozen (SRZN) |
United States |
$0.030B |
0.00 |
Incannex Healthcare (IXHL) |
Australia |
$0.029B |
0.00 |
Carisma Therapeutics (CARM) |
United States |
$0.029B |
0.00 |
Lipocine (LPCN) |
United States |
$0.028B |
0.00 |
Enlivex Therapeutics (ENLV) |
Israel |
$0.027B |
0.00 |
Natural Alternatives (NAII) |
United States |
$0.026B |
0.00 |
DURECT (DRRX) |
United States |
$0.025B |
0.00 |
Citius Pharmaceuticals (CTXR) |
United States |
$0.024B |
0.00 |
Mannatech (MTEX) |
United States |
$0.022B |
0.00 |
Vivos Therapeutics (VVOS) |
United States |
$0.022B |
0.00 |
BioLineRx (BLRX) |
Israel |
$0.019B |
0.00 |
GlycoMimetics (GLYC) |
United States |
$0.019B |
0.00 |
MEI Pharma (MEIP) |
United States |
$0.019B |
0.00 |
Cosmos Health (COSM) |
United States |
$0.018B |
0.00 |
Minerva Neurosciences (NERV) |
United States |
$0.016B |
0.00 |
ProPhase Labs (PRPH) |
United States |
$0.016B |
0.00 |
Traws Pharma (TRAW) |
United States |
$0.016B |
0.00 |
Marinus Pharmaceuticals (MRNS) |
United States |
$0.015B |
0.00 |
NRx Pharmaceuticals (NRXP) |
United States |
$0.015B |
0.00 |
TherapeuticsMD (TXMD) |
United States |
$0.015B |
0.00 |
Relmada Therapeutics (RLMD) |
United States |
$0.014B |
0.00 |
Lyra Therapeutics (LYRA) |
United States |
$0.014B |
0.00 |
PolyPid (PYPD) |
Israel |
$0.014B |
0.00 |
CERo Therapeutics Holdings (CERO) |
United States |
$0.013B |
0.00 |
Nuvilex (PMCB) |
United States |
$0.012B |
0.00 |
Talphera (TLPH) |
United States |
$0.012B |
0.00 |
Jaguar Animal Health (JAGX) |
United States |
$0.012B |
0.00 |
Kiora Pharmaceuticals (KPRX) |
United States |
$0.011B |
0.00 |
Dominari Holdings (DOMH) |
United States |
$0.010B |
0.00 |
Redhill Biopharma (RDHL) |
Israel |
$0.010B |
0.00 |
Indaptus Therapeutics (INDP) |
United States |
$0.010B |
0.00 |
Conduit Pharmaceuticals (CDT) |
United States |
$0.010B |
0.00 |
Klotho Neurosciences (KLTO) |
United States |
$0.010B |
0.00 |
XTL Biopharmaceuticals (XTLB) |
Israel |
$0.009B |
0.00 |
Addex Therapeutics (ADXN) |
Switzerland |
$0.008B |
0.00 |
Plus Therapeutics (PSTV) |
United States |
$0.008B |
0.00 |
NLS Pharmaceutics (NLSP) |
Switzerland |
$0.008B |
0.00 |
Viracta Therapeutics (VIRX) |
United States |
$0.007B |
0.00 |
Xenetic Biosciences (XBIO) |
United States |
$0.007B |
0.00 |
Mangoceuticals (MGRX) |
United States |
$0.006B |
0.00 |
Ainos (AIMD) |
United States |
$0.006B |
0.00 |
TransCode Therapeutics (RNAZ) |
United States |
$0.006B |
0.00 |
Biomerica (BMRA) |
United States |
$0.005B |
0.00 |
Aditxt (ADTX) |
United States |
$0.005B |
0.00 |
60 Degrees Pharmaceuticals (SXTP) |
United States |
$0.004B |
0.00 |
Heatwurx (PCSA) |
United States |
$0.004B |
0.00 |
TNF Pharmaceuticals (TNFA) |
United States |
$0.004B |
0.00 |
SHINECO (SISI) |
China |
$0.004B |
0.00 |
XORTX Therapeutics (XRTX) |
Canada |
$0.004B |
0.00 |
Aptorum Group (APM) |
United Kingdom |
$0.004B |
0.00 |
Avenue Therapeutics (ATXI) |
United States |
$0.004B |
0.10 |
Sonoma Pharmaceuticals (SNOA) |
United States |
$0.004B |
0.00 |
Quoin Pharmaceuticals (QNRX) |
United States |
$0.004B |
0.00 |
InMed Pharmaceuticals (INM) |
Canada |
$0.004B |
0.00 |
Petros Pharmaceuticals (PTPI) |
United States |
$0.004B |
0.00 |
Alaunos Therapeutics (TCRT) |
United States |
$0.003B |
0.00 |
Bio-Path Holdings (BPTH) |
United States |
$0.003B |
0.00 |
Qualigen Therapeutics (QLGN) |
United States |
$0.003B |
0.00 |
Phio Pharmaceuticals (PHIO) |
United States |
$0.003B |
0.00 |
Molecular Templates (MTEM) |
United States |
$0.003B |
0.00 |
SciSparc (SPRC) |
Israel |
$0.003B |
0.00 |
Shuttle Pharmaceuticals Holdings (SHPH) |
United States |
$0.003B |
0.00 |
Salarius Pharmaceuticals (SLRX) |
United States |
$0.002B |
0.00 |
Clearmind Medicine (CMND) |
Canada |
$0.002B |
0.00 |
Galmed Pharmaceuticals (GLMD) |
Israel |
$0.002B |
0.00 |
China SXT Pharmaceuticals (SXTC) |
China |
$0.002B |
0.00 |
Altamira Therapeutics (CYTO) |
Bermuda |
$0.002B |
0.00 |
PainReform (PRFX) |
Israel |
$0.000B |
0.00 |
Universe Pharmaceuticals INC (UPC) |
China |
$0.000B |
0.00 |
Grifols, S.A (GRFS) |
Spain |
$0.000B |
0.00 |
4D Pharma (LBPS) |
United Kingdom |
$0.000B |
0.00 |
Procaps Group, S.A (PROC) |
Luxembourg |
$0.000B |
4.65 |
Patheon (PTHN) |
Netherlands |
$0.000B |
0.00 |
RVL Pharmaceuticals (RVLP) |
United States |
$0.000B |
0.00 |
Stevanato Group S.p.A (STVN) |
Italy |
$0.000B |
41.76 |